Full text is available at the source.
Abstract
Semaglutide and tirzepatide produce substantial weight loss during treatment.
- The extent of weight loss achieved with these medications is notable.
- The trajectory of weight regain after stopping treatment is unclear.
- Further investigation is needed to understand long-term weight management following discontinuation.
Simplified
GLP-1 Therapies